IMPORTANT REMINDERS: COVID-19 Update 1/4/2021

Tennessee Oncology is not yet giving the COVID-19 vaccine in any of our clinics. We have applied for approval to administer the COVID-19 vaccine at most of our locations. Final approval is pending.  When we are approved to give the vaccine, an injection appointment will need to be made in order to receive it due […]

Read More

Expert Insights on Metastatic Breast Cancer Awareness Day: Treating Patients by Subtype

View original from Targeted Oncology HERE. A number of targeted agents have been approved in the setting of metastatic breast cancer, which has allowed for more personalized treatment approaches and underscores the importance of genomic testing. The breast cancer treatment landscape continues to expand with the development of new and novel therapies that improve outcomes […]

Read More

OneOncology and Tennessee Oncology Present Twelve Posters at ASCO Quality and Care Symposium

Nashville, TN – October 7, 2020 – OneOncology, the partnership of independent community oncology practices, said today that physicians, pharmacists and value-based care experts across the OneOncology network will present five posters at the American Society of Clinical Oncology’s (ASCO) virtual Quality and Care Symposium and seven additional posters focused on insights from partner practice, […]

Read More

IMPORTANT REMINDERS: Tennessee Oncology’s COVID-19 Precaution Requirements

For the protection of our patients and employees, face masks, screening, and visitor restrictions remain in place at all Tennessee Oncology clinic and imaging locations, regardless of state and local guidelines. At some locations, to assure appropriate social distancing, patients may also be asked to wait in their vehicles until they can be seen. Face […]

Read More

Changing Patterns of Care in Multiple Myeloma

Current therapeutic options for multiple myeloma and best practices in dispensing medications throughout the COVID-19 pandemic. Episode 1 Treatment Evolution in Multiple Myeloma Looking at the current state of multiple myeloma management, experts discuss interest in novel therapies and MRD assessment to guide treatment. Transcript Bruce Feinberg, DO: Hello, and welcome to this AJMC® webcast […]

Read More